ABCA1 and fatty liver disease: Relative to wild-type mice, ApoE−/− mice fed an HFD exhibit reduced hepatic ABCA1 expression, whereas BBR treatment enhances the expression of ABCA1 and alleviates atherosclerotic lesions and hepatic steatosis (Ma et al., 2021a).